References: [1]Yanochko GM, et al. Investigation of ocular events associated with taprenepag isopropyl, a topical EP2 agonist in development for treatment of glaucoma. J Ocul Pharmacol Ther. 2014 Jun;30(5):429-39.
CAS Number: 1005549-94-9
Molecular Weight: 520.60
Compound Purity: 99.23
Research Area: Inflammation/Immunology; Endocrinology